131 related articles for article (PubMed ID: 9888564)
21. Evidence for an autocrine-paracrine role of adrenomedullin in the cultured rat adrenal zona glomerulosa cells.
Andreis PG; Albertin G; Conconi MT; Carraro G; Malendowicz LK; Ziolkowska A; Nussdorfer GG
Int J Mol Med; 2002 Oct; 10(4):401-5. PubMed ID: 12239585
[TBL] [Abstract][Full Text] [Related]
22. Adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP) in adrenal chromaffin cells.
Kobayashi H; Yanagita T; Yokoo H; Wada A
Peptides; 2001 Nov; 22(11):1895-901. PubMed ID: 11754978
[TBL] [Abstract][Full Text] [Related]
23. Proadrenomedullin N-terminal 20 peptide (PAMP) enhances proliferation of rat zona glomerulosa cells by activating MAPK cascade.
Rebuffat P; Gottardo L; Malendowicz LK; Neri G; Nussdorfer GG
Peptides; 2001 Nov; 22(11):1909-12. PubMed ID: 11754980
[TBL] [Abstract][Full Text] [Related]
24. Pref-1, SF-1 and adrenocortical zonation.
Raza FS; Puddefoot JR; Vinson GP
Endocr Res; 1998; 24(3-4):977-81. PubMed ID: 9888610
[TBL] [Abstract][Full Text] [Related]
25. Adrenomedullin enhances cell proliferation and deoxyribonucleic acid synthesis in rat adrenal zona glomerulosa: receptor subtype involved and signaling mechanism.
Andreis PG; Markowska A; Champion HC; Mazzocchi G; Malendowicz LK; Nussdorfer GG
Endocrinology; 2000 Jun; 141(6):2098-104. PubMed ID: 10830296
[TBL] [Abstract][Full Text] [Related]
26. Specific binding sites for proadrenomedullin N-terminal 20 peptide (PAMP) in the rat.
Iwasaki H; Hirata Y; Iwashina M; Sato K; Marumo F
Endocrinology; 1996 Jul; 137(7):3045-50. PubMed ID: 8770930
[TBL] [Abstract][Full Text] [Related]
27. Effects of endothelin-1 on its receptor concentration and thymidine incorporation in calf adrenal zona glomerulosa cells: a comparative study with phorbol esters.
Cozza EN; Gomez-Sanchez CE
Endocrinology; 1990 Aug; 127(2):549-54. PubMed ID: 2164911
[TBL] [Abstract][Full Text] [Related]
28. Effect of adrenomedullin on aldosterone secretion by dispersed rat adrenal zona glomerulosa cells.
Yamaguchi T; Baba K; Doi Y; Yano K
Life Sci; 1995; 56(6):379-87. PubMed ID: 7830499
[TBL] [Abstract][Full Text] [Related]
29. The role of endothelial cell products in the regulation of adrenocortical function: actions of endothelin, nitric oxide, adrenomedullin and PAMP.
Hinson JP; Kapas S
Horm Metab Res; 1998; 30(6-7):334-40. PubMed ID: 9694559
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of aldosterone production by adrenomedullin, a hypotensive peptide, in the rat.
Yamaguchi T; Baba K; Doi Y; Yano K; Kitamura K; Eto T
Hypertension; 1996 Aug; 28(2):308-14. PubMed ID: 8707399
[TBL] [Abstract][Full Text] [Related]
31. Adrenomedullin and calcitonin gene-related peptide (CGRP) interact with a common receptor of the CGRP1 subtype in the human adrenal zona glomerulosa.
Belloni AS; Andreis PG; Meneghelli V; Champion HC; Kadowitz PJ; Coy DH; Murphy WA; Nussdorfer GG
Endocr Res; 1999 Feb; 25(1):29-34. PubMed ID: 10098591
[TBL] [Abstract][Full Text] [Related]
32. Adrenomedullin receptor is found exclusively in noradrenaline-secreting cells of the rat adrenal medulla.
Renshaw D; Thomson LM; Michael GJ; Carroll M; Kapas S; Hinson JP
J Neurochem; 2000 Apr; 74(4):1766-72. PubMed ID: 10737636
[TBL] [Abstract][Full Text] [Related]
33. Disabled-2 is expressed in adrenal zona glomerulosa and is involved in aldosterone secretion.
Romero DG; Yanes LL; de Rodriguez AF; Plonczynski MW; Welsh BL; Reckelhoff JF; Gomez-Sanchez EP; Gomez-Sanchez CE
Endocrinology; 2007 Jun; 148(6):2644-52. PubMed ID: 17303656
[TBL] [Abstract][Full Text] [Related]
34. In vitro steroidogenic effects of neuropeptide Y (NPY1-36), Y1 and Y2 receptor agonists (Leu31-Pro34 NPY, NPY18-36) and peptide YY (PYY) on rat adrenal capsule/zona glomerulosa.
Bernet F; Maubert E; Bernard J; Montel V; Dupouy JP
Regul Pept; 1994 Aug; 52(3):187-93. PubMed ID: 7800851
[TBL] [Abstract][Full Text] [Related]
35. Proadrenomedullin N-terminal 20 peptide (PAMP), acting through PAMP(12-20)-sensitive receptors, inhibits Ca2+-dependent, agonist-stimulated secretion of human adrenal glands.
Belloni AS; Rossi GP; Andreis PG; Aragona F; Champion HC; Kadowitz PJ; Murphy WA; Coy DH; Nussdorfer GG
Hypertension; 1999 May; 33(5):1185-9. PubMed ID: 10334809
[TBL] [Abstract][Full Text] [Related]
36. Inhibitory effect of adrenomedullin (ADM) on the aldosterone response of human adrenocortical cells to angiotensin-II: role of ADM(22-52)-sensitive receptors.
Belloni AS; Andreis PG; Rossi GP; Mingrino A; Champion HC; Kadowitz PJ; Murphy WA; Coy DH; Nussdorfer GG
Life Sci; 1998; 63(26):2313-21. PubMed ID: 9877221
[TBL] [Abstract][Full Text] [Related]
37. Expression of adrenomedullin and proadrenomedullin N-terminal 20 peptide in human and rat prostate.
Jiménez N; Calvo A; Martínez A; Rosell D; Cuttitta F; Montuenga LM
J Histochem Cytochem; 1999 Sep; 47(9):1167-78. PubMed ID: 10449538
[TBL] [Abstract][Full Text] [Related]
38. Vasoactive intestinal peptide is a local regulator of adrenocortical function.
Hinson JP; Ho MM; Vinson GP; Kapas S
Endocr Res; 1996 Nov; 22(4):831-8. PubMed ID: 8969946
[TBL] [Abstract][Full Text] [Related]
39. Proadrenomedullin-derived peptides in the paracrine control of the hypothalamo-pituitary-adrenal axis.
Nussdorfer GG
Int Rev Cytol; 2001; 206():249-84. PubMed ID: 11407762
[TBL] [Abstract][Full Text] [Related]
40. Expression of proadrenomedullin derived peptides in the mammalian pituitary: co-localization of follicle stimulating hormone and proadrenomedullin N-20 terminal peptide-like peptide in the same secretory granules of the gonadotropes.
Montuenga LM; Burrell MA; Garayoa M; Llopiz D; Vos M; Moody T; García-Ros D; Martínez A; Villaro AC; Elsasser T; Cuttitta F
J Neuroendocrinol; 2000 Jul; 12(7):607-17. PubMed ID: 10849205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
